Search
for
Sort by
Research 421–450 of 1000+
- HX17 The fortunate side effect: serendipity and therapeutic innovation in dermatology
- Use of Jak Inhibitors in the Treatment of Alopecia Areata
- Comparative Efficacy of JAK Inhibitors in Acute vs Nonacute Alopecia Areata: A Retrospective Cohort Study
- MODERN TREATMENT APPROACHES FOR ALOPECIA: CURRENT ADVANCES AND FUTURE PERSPECTIVES
- MODERN TREATMENT APPROACHES FOR ALOPECIA: CURRENT ADVANCES AND FUTURE PERSPECTIVES
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- S3 guideline diagnostics and therapy in alopecia areata – Part 2: Therapy, psychosocial and cosmetic support
- Suspected upadacitinib-associated drug hypersensitivity mimicking disease exacerbation in ulcerative colitis
- TOFACITINIB IN OVERLAPPING AUTOIMMUNE AND AUTOINFLAMMATORY DISORDERS: A CASE REPORT OF A DUAL GRAHAM-LITTLE-PICCARDI-LASSEUR SYNDROME AND HIDRADENITIS SUPPURATIVA
- The Possible Role of Antibodies in Alopecia: A Narrative Review
- Alopecia Areata and Atopic Dermatitis: Common Mechanisms and Emerging Therapeutics
- Clinical positioning and future prospects of JAK inhibitors in alopecia areata
- CURRENT UNDERSTANDING OF VITILIGO: A COMPREHENSIVE LITERATURE REVIEW
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- UHPLC-Q-Orbitrap HRMS-based Metabolomics and In Silico Studies on 5-α-Reductase, JAK1, JAK2, and JAK3 of <i>Albizia saponaria</i> L.: Application to Alopecia
- Alopecia and Mental Health: Psychosocial Burden, Neuroendocrine Mechanisms, and Therapeutic Implications
- Alopecia and Mental Health: Psychosocial Burden, Neuroendocrine Mechanisms, and Therapeutic Implications
- Effectiveness of Baricitinib on Nail Alopecia Areata: A 48-Week Single-Center Retrospective Study
- The Economic Burden of Alopecia Areata: Evidence from a Survey in Norway and Sweden
- Epidemiology, Diagnosis and Management of Alopecia Areata: An Asia‐Pacific Modified Delphi Expert Panel Recommendations
- Alopecia Areata: A Comprehensive Review of Pathogenesis, Diagnosis, and Emerging Therapeutics
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Overcoming genetic drivers in alopecia areata: hair regrowth in a patient with <i>AIRE</i> gene mutation (autoimmune polyendocrinopathy–candidiasis–ectodermal dystrophy, APECED syndrome) treated with ruxolitinib
- Clinical evidence for JAK inhibition in alopecia areata: A comprehensive review
- Irish dermatologists’ experience with JAK inhibitors in alopecia areata
- Tangled Causes, Targeted Solutions: A Comprehensive Review of Alopecia.
- A Successful Treatment of Alopecia Universalis with Ruxolitinib
- Comparative analysis of therapeutic outcomes in pediatric versus adult ophiasis-pattern alopecia areata: A review of treatment modalities and disease course